Literature DB >> 16841371

Expression of the TAL1/SCL transcription factor in physiological and pathological vascular processes.

T Tang1, Y Shi, S R Opalenik, D M Brantley-Sieders, J Chen, J M Davidson, S J Brandt.   

Abstract

The TAL1/SCL transcription factor is essential for haematopoietic commitment and vascular remodelling during embryonic development. To help clarify its role in postnatal vascular processes, we characterized the expression of mouse Tal1 protein by immunocytochemistry in several experimental models of blood vessel formation. In adult mice, Tal1 protein was expressed in rare microvascular endothelial cells and in extravascular cells provisionally identified as endothelial progenitors from their morphology, proximity to vessels and expression of vascular endothelial growth factor receptor-2. The number of Tal1-expressing endothelial cells increased significantly but transiently in all the models-hormone-induced ovulation, wound healing and tumour development. Finally, Tal1 protein was detected in the nuclei of newly formed lymphatic endothelial cells in tumour-bearing animals. These results show that TAL1 is expressed by vascular endothelial cells and endothelial progenitors at sites of physiological and pathological neovascularization and suggest a role for this transcription factor in adult vasculogenesis. This work also provides the first evidence for TAL1 expression in lymphangiogenesis. Copyright (c) 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16841371     DOI: 10.1002/path.2028

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors.

Authors:  Soumyadeep Dey; David J Curtis; Stephen M Jane; Stephen J Brandt
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

2.  The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.

Authors:  Dita Gratzinger; Shuchun Zhao; Robert West; Robert V Rouse; Hannes Vogel; Elena Cubedo Gil; Ronald Levy; Izidore S Lossos; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2009-02       Impact factor: 2.493

3.  Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis.

Authors:  Ryan J Wozniak; Sunduz Keles; Jesse J Lugus; Ken H Young; Meghan E Boyer; Tuan M Tran; Kyunghee Choi; Emery H Bresnick
Journal:  Mol Cell Biol       Date:  2008-09-08       Impact factor: 4.272

4.  The transcription factor complex LMO2/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis.

Authors:  Yoshihiro Yamada; Yi Zhong; Shiho Miki; Akiko Taura; Terence H Rabbitts
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

5.  Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.

Authors:  Virginie Deleuze; Rawan El-Hajj; Elias Chalhoub; Christiane Dohet; Valérie Pinet; Philippe Couttet; Danièle Mathieu
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.